1263371-66-9

Upstream product

• 1263374-08-8 5'-chloro-2'-fluoro-N-(3-fluorobenzyl)-[2,4'-dipyridine]-6-amine 
• 71830-07-4 (1S,3R)-3-aminocyclopentanecarboxylic acid 
• 100-82-3 (3-fluorophenyl)methanamine 
• 626-05-1 2,6-Dibromopyridine 
• 1263374-07-7 6-bromo-N-(3-fluorobenzyl)pyridine-2-amine 

Downstream Products

• 1263371-70-5 (1S,3R)-3-(5'-chloro-6-(3-fluorobenzylamino)-2,4'-bipyridin-2'-yl-amino)-N,N-dimethylcyclopentanecarboxamide 

Relevant academic research and scientific papers

SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 1NHIBITORS AND THEIR USES

The present invention provides a compound of formula (II) where R1 is a substituted alkyl, heterocyclic, or cycloalkyl, group, and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tan-tomers, diastereomers, or racemates thereof, and pharmaceutical compositions comprising these compounds. Also provided are methods of using these compounds to treat a disease or condition mediated by CDK9, such as cancersand other conditions described herein

Heteroaryl Compounds and Their Uses

The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.